The NOX2-mediated ROS producing capacity of recipient cells is associated with reduced T cell infiltrate in an experimental model of chronic renal allograft inflammation

Transplant Immunology

Volumn 30, Issue 2-3, 2014, Pages 65-70

  Kraaij, Marina D ^a   Koekkoek, Karin M ^a   Gelderman, Kyra A ^a,b   Van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Macrophage; ROS; T cell; Transplantation

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRANSCRIPTION FACTOR FOXP3; CYBB PROTEIN, RAT; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC INFLAMMATION; CONTROLLED STUDY; GRAFT RECIPIENT; INFLAMMATORY CELL; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; ALLOGRAFT; ANIMAL; DISEASE MODEL; GENETICS; GRAFT REJECTION; IMMUNOLOGY; INFLAMMATION; LEWIS RAT; PATHOLOGY; REGULATORY T LYMPHOCYTE;

ALLOGRAFTS; ANIMALS; DISEASE MODELS, ANIMAL; GRAFT REJECTION; INFLAMMATION; KIDNEY TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; RATS; RATS, INBRED LEW; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES, REGULATORY;

EID: 84896548431     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.12.001     Document Type: Article

References (32)

1. Sayegh M.H., Turka L.A. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998, 338:1813-1821.
2. Nankivell B.J., Alexander S.I. Rejection of the kidney allograft. N Engl J Med 2010, 363:1451-1462.
3. Wood K.J., Bushell A., Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012, 12:417-430.
4. Wyburn K.R., Jose M.D., Wu H., Atkins R.C., Chadban S.J. The role of macrophages in allograft rejection. Transplantation 2005, 80:1641-1647.
5. Bestard O., Cunetti L., Cruzado J.M., Lucia M., Valdez R., Olek S., et al. Intragraft regulatory T cells in protocol biopsies retain Foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant 2011, 11:2162-2172.
6. Dummer C.D., Carpio V.N., Goncalves L.F.S., Manfro R.C., Veronese F.V. FOXP3(+) regulatory T cells: from suppression of rejection to induction of renal allograft tolerance. Transpl Immunol 2012, 26:1-10.
7. Taflin C., Nochy D., Hill G., Frouget T., Rioux N., Verine J., et al. Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function. Transplantation 2010, 89:194-199.
8. Duffield J.S. Macrophages and immunologic inflammation of the kidney. Semin Nephrol 2010, 30:234-254.
9. Jose M.D., Ikezumi Y., van R.N., Atkins R.C., Chadban S.J. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003, 76:1015-1022.
10. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
11. Hultqvist M., Olsson L.M., Gelderman K.A., Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol 2009, 30:201-208.
12. Kraaij M.D., Savage N.D., van der Kooij S.W., Koekkoek K., Wang J., van den Berg J.M., et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 2010, 107:17686-17691.
13. Gelderman K.A., Hultqvist M., Pizzolla A., Zhao M., Nandakumar K.S., Mattsson R., et al. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 2007, 117:3020-3028.
14. Hultqvist M., Olofsson P., Holmberg J., Backstrom B.T., Tordsson J., Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 2004, 101:12646-12651.
15. Olofsson P., Holmberg J., Tordsson J., Lu S.M., Akerstrom B., Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2003, 33:25-32.
16. Tran T.N., Eubanks S.K., Schaffer K.J., Zhou C.Y.J., Linder M.C. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 1997, 90:4979-4986.
17. Denecke C., Reutzel-Selke A., Sawitzki B., Boenisch O., Khalpey Z., Seifert M., et al. Low-dose cyclosporine mediates donor hyporesponsiveness in a fully mismatched rat kidney transplant model. Transpl Immunol 2012, 26:176-185.
18. Joosten S.A., van Dixhoorn M.G.A., Borrias M.C., Benediktsson H., van Veelen P.A., van Kooten C., et al. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol 2002, 160:1301-1310.
19. Heemann U.W., Tullius S.G., Tamatami T., Miyasaka M., Milford E., Tilney N.L. Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat-kidney allografts. Transpl Int 1994, 7:349-355.
20. Martins P.N., Reutzel-Selke A., Jurisch A., Denecke C., Attrot K., Pascher A., et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 2006, 82:938-944.
21. Kraaij M.D., van der Kooij S.W., Reinders M.E., Koekkoek K., Rabelink T.J., van Kooten C., et al. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol 2011, 49:549-557.
22. Campise M., Bamonti F., Novembrino C., Ippolito S., Tarantino A., Cornelli U., et al. Oxidative stress in kidney transplant patients. Transplantation 2003, 76:1474-1478.
23. Oberg B.P., McMenamin E., Lucas F.L., McMonagle E., Morrow J., Ikizler T.A., et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004, 65:1009-1016.
24. Matsue H., Edelbaum D., Shalhevet D., Mizumoto N., Yang C.D., Mummert M.E., et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 2003, 171:3010-3018.
25. Schmielau J., Finn O.J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res 2001, 61:4756-4760.
26. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002, 3:1129-1134.
27. Pillay J., Kamp V.M., van H.E., Visser T., Tak T., Lammers J.W., et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012, 122:327-336.
28. Salcido-Ochoa F., Yusof N., Hue S.S., Haase D., Kee T., Rotzschke O. Are we ready for the use of foxp3(+) regulatory T cells for immunodiagnosis and immunotherapy in kidney transplantation?. J Transplant 2012, 2012:397952.
29. Tiemessen M.M., Jagger A.L., Evans H.G., van Herwijnen M.J.C., John S., Taams L.S. CD4(+)CD25(+)Foxp3(+) regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 2007, 104:19446-19451.
30. Miyasato K., Takabatake Y., Kaimori J., Kimura T., Kitamura H., Kawachi H., et al. CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats. Clin Exp Nephrol 2011, 15:50-57.
31. Graca L., Cobbold S.P., Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002, 195:1641-1646.
32. Kraaij M.D., Koekkoek K.M., van der Kooij S.W., Gelderman K.A., van Kooten C. Subsets of human type 2 macrophages show differential capacity to produce reactive oxygen species. Cell Immunol 2013, 284:1-8.